Reliq Health Technologies Inc.
RQHTF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $4,741 | $4,119 | $3,472 | $2,289 |
| % Growth | 15.1% | 18.6% | 51.7% | – |
| Cost of Goods Sold | $1,539 | $2,701 | $3,006 | $1,754 |
| Gross Profit | $3,202 | $1,418 | $466 | $535 |
| % Margin | 67.5% | 34.4% | 13.4% | 23.4% |
| R&D Expenses | $633 | $1,003 | $801 | $656 |
| G&A Expenses | $858 | $822 | $2,057 | $669 |
| SG&A Expenses | $1,928 | $422 | $2,074 | $744 |
| Sales & Mktg Exp. | $34 | $49 | $16 | $75 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,627 | $1,424 | $1,194 | $1,786 |
| Operating Income | $612 | -$7 | -$728 | -$1,251 |
| % Margin | 12.9% | -0.2% | -21% | -54.7% |
| Other Income/Exp. Net | $119 | -$65 | $611 | $256 |
| Pre-Tax Income | $731 | -$71 | -$122 | -$995 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $731 | -$71 | -$122 | -$995 |
| % Margin | 15.4% | -1.7% | -3.5% | -43.5% |
| EPS | 0.004 | -0 | -0.001 | -0.005 |
| % Growth | 1,100% | 33.3% | 88.7% | – |
| EPS Diluted | 0.004 | -0 | -0.001 | -0.005 |
| Weighted Avg Shares Out | 182,754 | 195,759 | 189,356 | 188,581 |
| Weighted Avg Shares Out Dil | 182,754 | 195,759 | 189,356 | 188,581 |
| Supplemental Information | – | – | – | – |
| Interest Income | $162 | $153 | $81 | $77 |
| Interest Expense | $5 | $7 | $6 | $8 |
| Depreciation & Amortization | $28 | $30 | $28 | $35 |
| EBITDA | $641 | -$76 | -$700 | -$952 |
| % Margin | 13.5% | -1.8% | -20.2% | -41.6% |